Cargando…

Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions

Alzheimer’s disease (AD) is the most common age-related dementia. The alteration in metabolic characteristics determines the prognosis. Patients at risk show reduced glucose uptake in the brain. Additionally, type 2 diabetes mellitus increases the risk of AD with increasing age. Therefore, changes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Vijay, Kim, So-Hyeon, Bishayee, Kausik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455726/ https://www.ncbi.nlm.nih.gov/pubmed/36076944 http://dx.doi.org/10.3390/ijms23179540

Ejemplares similares

Editorial: Molecular mechanisms in neural development, related disorders, and therapeutic treatments
por: Kumar, Vijay, et al.
Publicado: (2023)

Oxidative stress in cerebrovascular disease and associated diseases
por: Kumar, Vijay, et al.
Publicado: (2023)

Glucose Metabolic Brain Networks in Early-Onset vs. Late-Onset Alzheimer's Disease
por: Chung, Jinyong, et al.
Publicado: (2016)

The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells
por: Bishayee, Kausik, et al.
Publicado: (2023)

Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
por: Park, Jong-Chan, et al.
Publicado: (2023)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Dysfunctional gene splicing in glucose metabolism may contribute to Alzheimer's disease
por: Deng, Shengfeng, et al.
Publicado: (2023)

Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer’s Disease
por: Sultana, Most Arifa, et al.
Publicado: (2023)

mTORC1-Inhibition Potentiating Metabolic Block by Tyrosine Kinase Inhibitor Ponatinib in Multiple Myeloma
por: Nazim, Uddin Md., et al.
Publicado: (2022)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Condurango (Gonolobus condurango) Extract Activates Fas Receptor and Depolarizes Mitochondrial Membrane Potential to Induce ROS-dependent Apoptosis in Cancer Cells in vitro: CE-treatment on HeLa: a ROS-dependent mechanism
por: Bishayee, Kausik, et al.
Publicado: (2015)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Azoxystrobin Impairs Neuronal Migration and Induces ROS Dependent Apoptosis in Cortical Neurons
por: Kang, Jieun, et al.
Publicado: (2021)

Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer’s Disease
por: Bailey-Taylor, Melissa J., et al.
Publicado: (2022)

Language and communication non-pharmacological interventions in patients with Alzheimer's disease: a systematic review. Communication intervention in Alzheimer
por: Morello, Aline Nunes da Cruz, et al.
Publicado: (2017)

Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease
por: Wang, Qianqian, et al.
Publicado: (2022)

Identification of potential targets of cinnamon for treatment against Alzheimer’s disease-related GABAergic synaptic dysfunction using network pharmacology
por: Qian, Dongdong, et al.
Publicado: (2022)

Mitochondrial dysfunction and Alzheimer’s disease: prospects for therapeutic intervention
por: Lim, Ji Woong, et al.
Publicado: (2020)

Pharmacological Advances in the Management of Sexual Dysfunction
por: Reddy, M. S., et al.
Publicado: (2017)

Angelica polymorpha Maxim Induces Apoptosis of Human SH-SY5Y Neuroblastoma Cells by Regulating an Intrinsic Caspase Pathway
por: Rahman, Md. Ataur, et al.
Publicado: (2016)

Evidence of an Epigenetic Modification in Cell-cycle Arrest Caused by the Use of Ultra-highly-diluted Gonolobus Condurango Extract
por: Bishayee, Kausik, et al.
Publicado: (2013)

Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease
por: Wang, Liao-Yao, et al.
Publicado: (2020)

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
por: Brandon, Jason A., et al.
Publicado: (2018)

The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease
por: Murphy, Jiayuan, et al.
Publicado: (2022)

The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease
por: Bukke, Vidyasagar Naik, et al.
Publicado: (2020)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
por: Tang, Jason, et al.
Publicado: (2019)

The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease
por: Tondo, Giacomo, et al.
Publicado: (2020)

Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer’s Disease Patients
por: Ribarič, Samo
Publicado: (2022)

PLGA-Loaded Gold-Nanoparticles Precipitated with Quercetin Downregulate HDAC-Akt Activities Controlling Proliferation and Activate p53-ROS Crosstalk to Induce Apoptosis in Hepatocarcinoma Cells
por: Bishayee, Kausik, et al.
Publicado: (2015)

Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease
por: Bischof, Gérard N., et al.
Publicado: (2016)

Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
por: Scheltens, Nienke M.E., et al.
Publicado: (2019)

Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways
por: Rosenthal, Samantha L., et al.
Publicado: (2014)

Therapeutic Approaches to Delay the Onset of Alzheimer's Disease
por: Kumar, Raj, et al.
Publicado: (2011)

Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2022)

Post-cancer Treatment with Condurango 30C Shows Amelioration of Benzo[a]pyrene-induced Lung Cancer in Rats Through the Molecular Pathway of Caspa- se-3-mediated Apoptosis Induction: -Anti-lung cancer potential of Condurango 30C in rats-
por: Sikdar, Sourav, et al.
Publicado: (2013)

Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
por: Kim, Jae Kwang, et al.
Publicado: (2017)

Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
por: Muszyński, Paweł, et al.
Publicado: (2021)

Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer’s disease
por: Choi, Hongyoon, et al.
Publicado: (2021)

Erectile Dysfunction: Pharmacological Pathways with Understudied Potentials
por: Adam, Doaa R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m431mfi54dk9h0dt987hapjahl